Author

J. Aerts

Primary ORCID profile (0000-0002-6416-2717 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

J. AertsiD2 papers · Hasselt University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:bacteria (other)· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

B. Valkenburg· 1 shared D. Ionescu· 1 shared D. Mercieca· 1 shared D. Vellone· 1 shared I. de Heer· 1 shared J. Ody· 1 shared J.-F. Flot· 1 shared L. Barbu-Tudoran· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Valkenburg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cave Thiovulaceae differ metabolically and genomically from marine species

M. Bizic, T. Brad, D. Ionescu, L. Barbu-Tudoran, J. Aerts, R. Popa, L. Zoccarato, J. Ody, J.-F. Flot, S. Tighe, D. Vellone, S. M. Sarbu

The paper compares the genomes of cave-dwelling Thiovulum species to a marine strain, revealing metabolic adaptations for sulfur and nitrogen cycling in subterranean environments.

bioRxiv · Nov 4, 2020 · PreprintMicrobiology

Effective Tyrosine Kinase Inhibitors result in the intracellular accumulation of EGFR and allows response prediction in patients

M. de Wit, Y. Gao, D. Mercieca, I. de Heer, B. Valkenburg, M. van Royen, J. Aerts, P. Sillevis Smitt, P. French

The paper shows that EGFR tyrosine kinase inhibitors (TKIs) cause intracellular EGFR accumulation only in specific mutation-TKI combinations, which predicts clinical response in patients.

bioRxiv · Oct 21, 2019 · PreprintCancer Biology